Clinical trial
Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock
NCT02716597 is registered in ClinicalTrials.gov with Alexander Flannery, 859-323-4011 as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock
- Lead sponsor
- Alexander Flannery, 859-323-4011
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- March 31, 2016
- Completion date
- January 31, 2019
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.